Agenus Inc. (AGEN)
NASDAQ: AGEN · Real-Time Price · USD
7.45
-0.33 (-4.24%)
Aug 6, 2026, 12:28 PM EDT - Market open
Agenus Employees
Agenus had 81 employees as of December 31, 2025. The number of employees decreased by 235 or -74.37% compared to the previous year.
Employees
81
Change (1Y)
-235
Growth (1Y)
-74.37%
Revenue / Employee
$1,529,210
Profits / Employee
$794,951
Market Cap
333.40M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 81 | -235 | -74.37% |
| Dec 31, 2024 | 316 | -73 | -18.77% |
| Dec 31, 2023 | 389 | -144 | -27.02% |
| Dec 31, 2022 | 533 | 92 | 20.86% |
| Dec 31, 2021 | 441 | 82 | 22.84% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Lyell Immunopharma | 161 |
| Zentalis Pharmaceuticals | 106 |
| Century Therapeutics | 78 |
| Upstream Bio | 75 |
| Lexeo Therapeutics | 59 |
| Vicore Pharma Holding AB | 40 |
| Compass Therapeutics | 39 |
| DiaMedica Therapeutics | 35 |
AGEN News
- 3 hours ago - Agenus Earnings release: Q2 2026 - Filings
- 4 hours ago - Agenus concentrates resources on ROBBIN, discontinues commitment to BATTMAN - TheFly
- 4 hours ago - Agenus reports Q2 revenue $34.5M vs $25.7M last year - TheFly
- 5 hours ago - Agenus Reports Second Quarter 2026 Results and Advances Phase 3 ROBBIN Trial of BOT+BAL in Neoadjuvant MSS Colon Cancer - Business Wire
- 7 days ago - Agenus Slides: Corporate presentation - Filings
- 7 days ago - Agenus price target raised to $14 from $8 at B. Riley - TheFly
- 8 days ago - Agenus to Provide Second Quarter 2026 Financial Report and Development Update - Business Wire
- 17 days ago - Agenus Registration statement: Registration filing - Filings